BioXcel Therapeutics, Inc. - Common Stock (BTAI)
Seasonality Analysis
BioXcel Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
BioXcel Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 7.20% | Weak | |
| February BEST | 18.14% | Very Strong | |
| March WORST | -16.56% | Very Weak | |
| April | -0.58% | Very Weak | |
| May | -1.04% | Weak | |
| June | -5.16% | Weak | |
| July | -4.30% | Very Weak | |
| August | 10.74% | Weak | |
| September | -15.76% | Very Weak | |
| October | 0.11% | Weak | |
| November | 0.51% | Weak | |
| December | 10.02% | Weak |
BioXcel Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
BioXcel Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
BioXcel Therapeutics, Inc. - Common Stock Pattern Scanner
BioXcel Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About BioXcel Therapeutics, Inc. - Common Stock (BTAI) Seasonality
BioXcel Therapeutics, Inc. - Common Stock (BTAI) has been analyzed using 9 years of historical data to identify seasonal patterns. Classified under Stocks, BioXcel Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for BioXcel Therapeutics, Inc. - Common Stock is historically February, with an average return of 18.14% and a win rate of 75%. Conversely, March tends to be the weakest month, averaging -16.56% return.
Looking at the full calendar year, BioXcel Therapeutics, Inc. - Common Stock has an average annual return of 3.33% with an overall monthly win rate of 41.1%. Out of 12 months, 6 typically show positive average returns.
The seasonal pattern for BioXcel Therapeutics, Inc. - Common Stock has a consistency score of 45.8 (Poor), based on 9 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
BioXcel Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy BioXcel Therapeutics, Inc. - Common Stock (BTAI)?
Historically, February has been the best month for BioXcel Therapeutics, Inc. - Common Stock, with an average return of 18.14% and a win rate of 75%. However, past performance does not guarantee future results.
What is the worst month for BioXcel Therapeutics, Inc. - Common Stock (BTAI)?
Based on historical data, March has been the weakest month for BioXcel Therapeutics, Inc. - Common Stock, with an average return of -16.56%. This is a historical observation and does not guarantee future results.
How reliable is BTAI seasonality data?
The seasonality analysis for BioXcel Therapeutics, Inc. - Common Stock is based on 9 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use BioXcel Therapeutics, Inc. - Common Stock seasonality in my trading?
Use BioXcel Therapeutics, Inc. - Common Stock (BTAI) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.